Fact-checked by Grok 2 weeks ago

Vaccine skepticism

Vaccine skepticism constitutes a critical stance toward policies and practices, emphasizing empirical scrutiny of vaccines' risk-benefit profiles, potential adverse effects, and the influences of and coercive mandates on decisions. This perspective prioritizes individual assessment of causal links between vaccines and documented harms, such as , , , and thrombotic events, which peer-reviewed analyses have associated with certain formulations, particularly mRNA-based vaccines. Skeptics often reference underreporting in passive surveillance systems like VAERS alongside historical precedents of vaccine-associated injuries, including paralytic cases linked to early oral polio vaccines and Guillain-Barré following swine flu campaigns. The roots of vaccine skepticism trace to the late 18th and early 19th centuries, when Edward Jenner's faced resistance in and the over concerns regarding contaminated lymph, severe side effects like and transmission, and violations of through compulsory laws. Organized opposition emerged via groups like the Anti- of in , which challenged the 1853 Vaccination Act's mandates on sanitary, religious, and libertarian grounds, leading to legal precedents affirming and exemptions. In the , skepticism intensified with revelations of Incident contamination in 1955, causing acute in over 200 children, and the 1976 swine flu vaccine program's suspension after elevated Guillain-Barré rates. Contemporary vaccine skepticism gained traction during the era, fueled by accelerated regulatory timelines, emergency authorizations, and mandates that overlooked stratified risk data—such as negligible severe outcomes in healthy youth—while adverse event signals emerged in multinational studies tracking AESIs like cardiac and neurological disorders post-vaccination. Defining characteristics include advocacy for , transparent , and alternatives like natural immunity or targeted prophylaxis over universal schedules, often citing causal evidence from disproportionality analyses in reporting databases that flag temporal associations warranting further . Controversies persist around institutional dismissal of skepticism as mere "hesitancy" despite validated risks, with meta-awareness of biases in academia and media—where funding ties to vaccine manufacturers may skew narratives—prompting reliance on primary data over consensus-driven interpretations.

Historical Development

Origins in the 19th Century

Vaccine skepticism emerged prominently in the late 18th and early 19th centuries alongside the introduction of Edward Jenner's smallpox inoculation method, first demonstrated in 1796 when Jenner inoculated an 8-year-old boy with cowpox material to confer immunity against smallpox. Initial adoption was widespread due to smallpox's lethality, but early practitioners observed risks from arm-to-arm vaccination techniques, which involved transferring lymph directly from infected donors, leading to transmissions of secondary infections such as erysipelas—a severe bacterial skin infection—and syphilis. These adverse events, documented in medical reports from the 1800s, fueled doubts about the procedure's safety, with critics arguing that the benefits did not outweigh the immediate harms observed in vaccinated individuals. Opposition intensified with Britain's Vaccination Acts, which progressively enforced mandatory smallpox vaccination. The 1840 Act provided free vaccination, while the 1853 Act required it for infants within three months of birth, prompting the formation of the Anti-Vaccination League in that year to contest compulsion and highlight cases of vaccine-associated illnesses. The 1867 Act extended requirements to subsequent children and increased penalties, eliciting widespread resistance based on empirical reports of outbreaks like following vaccination campaigns. In response, the National Anti-Compulsory Vaccination League was established in 1867, advocating against state coercion and citing firsthand accounts of healthy children developing severe complications post-inoculation, which skeptics viewed as causal evidence of vaccine risks over protective efficacy. In the United States, similar skepticism arose in the mid-19th century amid smallpox vaccination drives, with critics questioning the procedure's reliability based on observed failures and side effects, though organized resistance lagged behind Britain's. A notable example unfolded in , , where non-compliance surged in the 1880s following a 1885 anti-vaccination demonstration that drew tens of thousands protesting mandatory laws; vaccination rates dropped below 10% by the late 1880s as residents prioritized , , and notification over . During the 1892–1893 smallpox outbreak, recorded 19.6 deaths per million population—far below the national average of 84—despite low vaccination coverage, which skeptics attributed to improved and measures rather than protection, reinforcing arguments for alternative strategies grounded in observable correlations.

20th Century Expansion and Key Events

The Cutter Incident of 1955 marked a pivotal escalation in vaccine skepticism during the rollout of Jonas Salk's inactivated polio vaccine in the United States. Batches produced by Cutter Laboratories contained live poliovirus due to inadequate inactivation processes and insufficient regulatory oversight by the Division of Biologic Standards, resulting in approximately 40,000 cases of polio among vaccinated children, including over 200 instances of paralysis and at least 10 deaths. This event, which halted the national vaccination program within weeks, exposed vulnerabilities in manufacturing quality control and federal licensing procedures, prompting congressional investigations and the establishment of stricter safety protocols, while eroding public confidence in rapid vaccine deployment. In the 1970s and 1980s, concerns over the diphtheria-tetanus-pertussis (DTP) vaccine further amplified distrust, particularly regarding the whole-cell pertussis component's alleged link to and neurological disorders. Reports from the in the mid-1970s associated the vaccine with rare cases of , leading to a sharp decline in vaccination rates from around 80% to 30%, which nearly triggered pertussis epidemics. In the , a 1982 NBC documentary titled DPT: Vaccine Roulette highlighted parental testimonies of adverse reactions, including seizures and developmental issues, sparking widespread alarm, surging lawsuits that threatened vaccine supply, and temporary halts in pertussis vaccination in some regions amid debates over risk-benefit ratios. These episodes culminated in the 1986 , which created a no-fault compensation system to stabilize production but underscored ongoing perceptions of underreported risks. Postwar cultural shifts in the United States and Germany intertwined vaccine skepticism with rising naturopathic and holistic health philosophies, emphasizing natural immunity and bodily autonomy over medical intervention. In the U.S., the revival of naturopathy in the 1950s, exemplified by the founding of institutions like the National College of Naturopathic Medicine in 1956, promoted alternative therapies and critiqued pharmaceutical dominance, fostering opposition to expanding compulsory vaccination schedules amid growing parental rights advocacy. In Germany, longstanding naturopathic traditions, rooted in 19th-century movements but persisting postwar through associations advocating Lebensreform principles, correlated with lower vaccine uptake by framing immunization as unnatural and state overreach, influencing resistance to mandatory programs. These movements gained traction during the 1960s counterculture era, prioritizing informed consent and linking skepticism to broader critiques of institutional medicine's authority.

Influence of the Wakefield Study and MMR Controversy

The 1998 publication by and 12 co-authors in presented a case series of 12 children who reportedly developed intestinal inflammation and regressive developmental disorders, including , shortly after receiving the measles, mumps, and rubella (, hypothesizing a connection via persistent measles virus in the gut. The small sample size, lack of controls, and reliance on parental recall limited its evidential weight, yet it garnered extensive global media coverage, framing MMR as a potential trigger for and prompting widespread parental alarm over observed temporal proximities between vaccination and symptom onset. This exposure fueled a sharp decline in MMR uptake, particularly in the UK, where coverage fell from 92% in 1995 to 80% by 2003, correlating with heightened vaccine skepticism and demands for single-antigen alternatives. Skeptics emphasized anecdotal clusters of post-vaccination regressions reported by parents, interpreting these as signals of causality overlooked by aggregate data, while regulatory bodies and media initially amplified the narrative before later critiquing it. Investigations culminated in the paper's retraction on February 2, 2010, following revelations of ethical breaches—including invasive procedures on children without approval—data falsification, and undisclosed financial ties to litigation against vaccine producers, as detailed in a exposé deeming the study fraudulent. Despite the retraction, the controversy entrenched doubts about safety surveillance and institutional transparency, with skeptics arguing that fraud allegations served to discredit valid observational concerns rather than address them. Countering the hypothesis, epidemiological research such as the 2002 Danish by Madsen et al., analyzing 537,303 children born 1991–1998, reported no elevated risk ( 0.92 for vaccinated vs. unvaccinated) or temporal clustering post-MMR, leveraging national registries for comprehensive follow-up. Similar null findings emerged from subsequent meta-analyses and cohorts, including U.S. and studies, attributing 's apparent rise to broadened diagnostic criteria rather than vaccines. Persistent skepticism highlighted discrepancies, including VAERS reports of over 1,000 or cases temporally linked to MMR from 1990–2001, though these passive signals lack verification and cannot infer causation amid underreporting biases. Critics of dismissal noted potential subgroup vulnerabilities undetected in population-level designs, invoking from proximate events where is minimized. The fallout contributed to measles resurgences, with the experiencing over 1,300 cases in 2008—largely in under-vaccinated communities—and earlier 2000s outbreaks tied to hesitancy rather than primary failure, as evidenced by linking cases to imported wild strains. In the U.S., where MMR coverage dipped below 90% in some states post-controversy, localized outbreaks in the mid-2000s, such as Ohio's 2005–2006 community cluster of 369 cases, reflected similar dynamics of exemption-driven gaps, debated as evidence of waning immunity versus avoidance of perceived risks. These events spurred regulatory pushes for mandates but also amplified scrutiny of in responses.

COVID-19 Era Acceleration (2020–2025)

The rapid development and of mRNA-based vaccines in late 2020 intensified vaccine skepticism, as Phase 3 trials for Pfizer-BioNTech and vaccines demonstrated high short-term against symptomatic but relied on limited follow-up data of approximately two months, raising concerns among critics about insufficient long-term safety assessments amid the urgency of the . The U.S. granted to the Pfizer-BioNTech vaccine on December 11, 2020, followed by Moderna's on December 18, 2020, enabling widespread rollout despite ongoing debates over the compression of typical multi-year timelines into months. Skeptics, including physicians and public figures, highlighted Operation Warp Speed's accelerated processes as potentially compromising rigorous testing, with mandates for , , and in 2021 further amplifying perceptions of and eroding trust in regulatory bodies. From 2021 to 2023, reports of adverse events, particularly and in young males, contributed to heightened scrutiny, as the U.S. Centers for Disease Control and Prevention documented elevated incidence rates following mRNA vaccination, with adolescent males aged 16–17 experiencing up to 75.9 cases per million second doses administered. The (VAERS) recorded a surge in submissions, including correlations with signals, while Act releases of Pfizer's documents in 2022 revealed over 1,200 reported deaths and thousands of serious events in the initial post-authorization period, though these unverified reports were interpreted by skeptics as evidence of underreported risks despite VAERS limitations like voluntary reporting and lack of causality confirmation. Global analyses, such as those examining all-cause mortality post-vaccination, fueled debates, with some studies noting temporal associations in highly vaccinated populations, prompting calls for independent audits of surveillance data amid institutional assurances of rarity. By 2024–2025, skepticism manifested in policy shifts and behavioral trends, including the U.S. Department of Health and Human Services under Secretary Robert F. Kennedy Jr. announcing on August 5, 2025, the wind-down of federal mRNA vaccine development funding through BARDA, citing safety concerns and reallocating $500 million from 22 contracts to alternative technologies. Kindergarten vaccine exemption rates nationwide rose to 3.6% for the 2024–2025 school year, up from 3.3% the prior year, reflecting growing parental opt-outs amid lingering COVID-era distrust. In the UK, surveys indicated a broader erosion of vaccine confidence, with public discourse highlighting persistent safety doubts and a shift toward hesitancy beyond COVID-19 shots, as evidenced by declining uptake and increased questioning of jab efficacy and risks. These developments underscored a sustained acceleration in skepticism, driven by empirical observations of adverse signals and perceived institutional overreach.

Core Arguments Raised by Skeptics

Doubts on Vaccine Safety and Adverse Effects

Vaccine skeptics argue that certain have demonstrated causal associations with serious adverse effects in large-scale deployments, pointing to the 1976 swine flu vaccination campaign where the vaccine was administered to approximately 45 million Americans and linked to an elevated incidence of Guillain-Barré syndrome (GBS), a involving acute . Surveillance identified 1,098 GBS cases with onset between October 1, 1976, and January 31, 1977, with epidemiological analysis confirming a statistically significant risk increase of about 1 case per 100,000 vaccinations, approximately tenfold higher than baseline rates. This event prompted program suspension and illustrated how mass immunization can unmask rare but severe risks through post-licensure monitoring. Similar precedents include the withdrawal of the RotaShield rotavirus vaccine in July 1999, after post-marketing reports to the documented 101 confirmed or presumed cases of intussusception—a requiring surgical intervention—among vaccinated infants by early October 1999. Risk estimates projected up to 1 in 10,000 to 1 in 20,000 infants affected, leading to the vaccine's market removal despite pre-licensure trials showing no signal, underscoring skeptics' claims that clinical trials may underestimate population-level harms due to limited sample sizes and follow-up durations. Skeptics contend that adverse events are systematically underdiagnosed and underreported, with VAERS—a passive surveillance system—capturing fewer than 1% of actual incidents based on an analysis of over 35,000 potential vaccine-related events, where awareness and barriers contributed to the low yield. This underreporting factor, estimated at 1-10% or lower in various assessments, amplifies concerns over undetected signals, as historical withdrawals like RotaShield relied on amplified VAERS data post-launch. Biological mechanisms proposed by skeptics include molecular mimicry, where vaccine antigens structurally resemble host proteins, potentially triggering cross-reactive autoantibodies and autoimmune disorders such as GBS or myocarditis. Peer-reviewed reviews detail how this process, observed in experimental models and epidemiological clusters, may underlie post-vaccination autoimmunity, with epitope similarities between viral components in vaccines and self-tissues driving T-cell or B-cell dysregulation. Such causal pathways challenge dismissals of reports as coincidental, emphasizing immune system perturbations over rarity alone. Concerns extend to cumulative effects from expanded pediatric schedules, which skeptics argue overload immature immune systems via simultaneous exposures, potentially elevating risks through sustained or dysregulation. Comparative analyses of vaccinated and unvaccinated U.S. children aged 6-12 have reported higher odds ratios for diagnoses like allergies (OR 30.1), ADHD (OR 4.2), and (OR 4.2) in the vaccinated cohort, drawn from three medical practices' records totaling over 2,000 participants, though methodological critiques highlight self-selection in unvaccinated groups. These findings, while preliminary and contested for factors like healthcare , align with first-principles critiques of dosing multiple adjuvants and antigens without long-term comparator trials, suggesting unvaccinated populations may exhibit lower rates of atopic and neurodevelopmental disorders in select datasets.

Questions on Efficacy and Waning Immunity

Vaccine skeptics have highlighted the limited duration of protection offered by certain , arguing that waning immunity undermines claims of long-term and contributes to outbreaks in highly vaccinated populations. For instance, acellular pertussis vaccines demonstrate high initial effectiveness but experience significant waning after 4 years, with protection diminishing rapidly thereafter, leading to increased susceptibility in adolescents and adults. This pattern has been linked to recurrent epidemics, such as the 2010 pertussis outbreak, which reported 9,146 cases despite vaccination coverage exceeding 90% in many areas, with most pediatric patients having received recommended doses and infections disproportionately affecting older children and teens whose immunity had faded. Similar concerns have been raised regarding vaccines, where skeptics point to breakthrough infections during the 2021 Delta variant waves as evidence of incomplete or transient protection. Even after widespread , Delta-driven surges occurred in populations with high coverage, including clusters of infections among fully vaccinated individuals exhibiting viral loads comparable to those in unvaccinated cases. Observational data from this period revealed that vaccine effectiveness against infection declined over months, prompting boosters, yet skeptics contend this reflects inherent limitations in inducing durable immunity against evolving variants rather than temporary gaps. Skeptics further argue that natural immunity often outperforms vaccine-induced protection in real-world settings, citing empirical comparisons such as analyses of over 700,000 individuals. These studies found prior infection conferred stronger and longer-lasting immunity against reinfection, symptomatic disease, and hospitalization compared to two doses of mRNA vaccination, with natural immunity showing minimal waning over time versus rapid decline in vaccine-only protection. Such findings, skeptics maintain, suggest vaccines fail to replicate the broad, adaptive responses elicited by natural exposure, potentially explaining sustained transmission in vaccinated cohorts.

Concerns Over Ingredients, Additives, and Manufacturing

Vaccine skeptics have raised concerns about aluminum , commonly used in formulations like DTaP, HPV, and vaccines to enhance , citing potential from their biopersistence and translocation to the . Animal studies, including those in mice, demonstrate that of aluminum particles results in long-term cerebral accumulation, with non-linear dose responses leading to neurotoxic effects such as behavioral changes and , even at doses simulating human schedules. In humans, macrophagic myofasciitis (MMF), a condition characterized by persistent aluminum-laden macrophages at injection sites, has been associated with vaccines containing aluminum , correlating with chronic symptoms like muscle pain, fatigue, and in affected individuals, as evidenced by muscle findings and epidemiological links to history. These observations fuel debates over whether aluminum's slow clearance—persisting for years in some cases—contributes to autoimmune or neurological disorders, though mainstream regulatory bodies maintain its safety based on aggregate population data. Thimerosal, an ethylmercury-based preservative used in multi-dose vials of such as and some older formulations, has drawn scrutiny for potential neurodevelopmental risks prior to its precautionary removal from most U.S. childhood around 2001. Pre-removal exposure levels in infants reached up to 187.5 micrograms of mercury by six months of age from cumulative doses, prompting concerns analogous to methylmercury's known toxicity. Retrospective analyses, including vaccine safety datalink studies from the late 1990s, identified preliminary signals of associations with neurodevelopmental delays, tics, and speech issues, though subsequent large-scale reviews like those from of Medicine in 2004 rejected causality based on post-removal trends. Skeptics argue that the phase-out aligned with efforts to address rising diagnoses, highlighting ethylmercury's distinct but shared pathways with other mercury forms. Historical manufacturing lapses underscore broader production reliability issues, exemplified by simian virus 40 () contamination in inactivated vaccines administered to approximately 98 million Americans between 1955 and 1963, stemming from monkey kidney cells used for propagation. Official reviews confirm infectious in up to 10-30% of U.S. doses during this period, a polyomavirus oncogenic in but with inconclusive cancer links despite detectable DNA in some tumors. More recently, analyses of mRNA vaccine pharmacovigilance data, including from Danish cohorts of over 5 million doses, reveal batch-to-batch variations in serious rates for BNT162b2, with certain lots showing elevated risks of or other events potentially tied to production inconsistencies like lipid nanoparticle purity or mRNA integrity. Whistleblower accounts and databases further suggest lot-dependent and disparities, raising questions about scalable manufacturing under emergency authorizations. The use of human fetal cell lines, such as and derived from elective abortions in the , in the development and testing of vaccines including , varicella, and certain candidates (e.g., HEK-293 for adenovirus vectors or mRNA optimization), introduces concerns over residual cellular contaminants or DNA fragments in final products. These immortalized lines facilitate viral growth unattainable in animal cells, but skeptics highlight potential immunomodulatory effects from non-self human genetic material, alongside manufacturing purity challenges in downstream purification processes. Regulatory filings indicate such lines' role in preclinical testing for vaccines like Johnson & 's Ad26.COV2.S, amplifying debates on despite claims of no viable cells in administered doses.

Ethical, Philosophical, and Coercion-Based Objections

Vaccine skeptics raise ethical objections centered on the principle of bodily autonomy, asserting that individuals possess an inherent right to refuse medical interventions without , a stance rooted in post-World War II ethical standards. The of 1947, developed in response to Nazi medical experiments, explicitly requires that "the voluntary consent of the human subject is absolutely essential," emphasizing that consent must be free from duress and based on full disclosure of risks. Skeptics argue that vaccination mandates violate this code by compelling participation in what they view as experimental or unnecessary procedures, particularly when alternatives like natural immunity exist for certain populations. Philosophically, opponents contend that the risk-benefit analysis of favors individual assessment over blanket policies, especially for low-risk groups such as healthy children, where historical indicate substantial pre-vaccine declines in mortality attributable to improvements in , , and living standards rather than . For instance, mortality fell more than 90% from the late to the mid-20th century before the vaccine's introduction in 1963, prompting arguments that the absolute risks of intervention may exceed those of the diseases in modern contexts. This perspective draws on natural rights philosophy, prioritizing personal sovereignty and parental authority in decisions affecting minors, and critiques utilitarian approaches that subordinate individual harms to collective gains. Coercion-based objections highlight mandates as infringements on liberty, exemplified by policies that tied vaccination to employment, travel, or education, leading to job losses for non-compliant workers and framing refusal as a defense of personal agency. Skeptics further cite incentives, with the global vaccine market reaching $77 billion in 2023, as potential drivers of policy pressure, suggesting profit motives may eclipse ethical considerations in promoting universal uptake. Systemic distrust amplifies these concerns, informed by historical abuses like the (1932–1972), where U.S. Service researchers withheld penicillin from infected participants without , eroding faith in institutional safeguards against overreach. During the era, instances of dissenting experts reinforced perceptions of coerced conformity over open ethical debate.

Empirical Evidence and Scientific Debates

Data on Vaccine-Associated Risks and Surveillance Systems

The (VAERS), a passive mechanism co-managed by the CDC and FDA, has documented signals for following various vaccines, with reported rates ranging from approximately 1 to 10 cases per million doses administered across multiple vaccine types. For mRNA vaccines specifically, early VAERS analyses indicated rates of 11.1 cases per million doses for the Pfizer-BioNTech vaccine in the initial rollout period from December 2020 to January 2021. These figures derive from unverified public and healthcare provider submissions, which serve as early warning signals rather than confirmed causal attributions. VAERS data also reveal temporal clustering of sudden infant death syndrome (SIDS) reports post-vaccination, particularly following diphtheria-tetanus-acellular pertussis (DTaP) doses. An analysis of 1,048 cases reported to VAERS from 1990 onward found that 51% occurred within 3 days of vaccination and 75.5% within 7 days, with the remainder distributed beyond that interval. A separate review of 2,605 deaths in VAERS through 2019 similarly identified 58% clustering within 3 days post-vaccination, highlighting non-uniform temporal patterns in passive reporting data. Such clusters prompt further scrutiny, though VAERS limitations include underreporting, overreporting, and lack of denominator data for incidence rates. In the UK, the scheme, operated by the Medicines and Healthcare products Regulatory Agency (MHRA), received over 1,500 reports of fatalities temporally associated with vaccines by mid-2021, amid broader monitoring through 2025. () Pharmacovigilance Risk Assessment Committee (PRAC) reviews have similarly cataloged menstrual disruptions following mRNA vaccines, with over 34,000 global reports of prompting updates to product information acknowledging a possible association by 2022. These included transient changes in cycle length and increased bleeding volume, observed in cohort and self-report data, with PRAC noting patterns warranting signal evaluation despite initial assessments finding no definitive causality. Cohort comparisons from the German KiGGS survey (2003–2006, with analyses extending into later reviews) indicate higher prevalence of allergic conditions among vaccinated children versus unvaccinated controls. Unvaccinated children aged 1–17 years reported lower rates of asthma (2.9% vs. 4.2% in partially vaccinated) and atopic eczema (10.9% vs. higher in vaccinated groups), based on parent-reported data from over 17,000 participants. These findings, drawn from a nationally representative sample, suggest differential health outcomes by vaccination status, though confounders like healthcare access and reporting bias require consideration in interpretation.

Evidence of Vaccine Benefits and Mortality Reductions

Vaccines have been credited with substantial reductions in mortality from infectious diseases, particularly through targeted eradication campaigns and widespread immunization programs. For , the World Health Organization's global vaccination efforts culminated in the last naturally occurring case in on October 26, 1977, leading to official eradication certification in 1980, marking the only human disease fully eliminated through . This success involved ring vaccination strategies that interrupted transmission chains, preventing an estimated 300-500 million deaths in the alone. However, historical fatality rates for unvaccinated cases remained around 30% throughout much of the disease's history, with earlier declines in incidence and lethality in regions like attributed partly to , practices, and predating Jenner's 1796 . In the case of poliomyelitis, the Global Polio Eradication Initiative, launched in 1988, has reduced wild cases by over 99%, from an estimated 350,000 annually across 125 countries to fewer than 100 in recent years, confined to and . Oral and inactivated vaccines administered in mass campaigns have been central to this progress, averting in millions. Yet, epidemiological analyses indicate that 's rise as a paralytic disease in the early coincided with sanitation improvements that delayed exposure from infancy—when infections were asymptomatic—to older ages, increasing severity; pre-vaccine declines in some developed areas, such as the U.S. from the 1950s peak, overlapped with further advancements and diagnostic refinements that excluded non-paralytic cases post-1954 vaccine . For measles, the introduction of the live in correlated with a precipitous drop in reported cases from approximately 500,000 annually to under 100 by the , alongside near-elimination of associated mortality, which averaged 400-500 deaths per year pre-vaccine. Globally, vaccination has prevented an estimated 56 million deaths between 2000 and 2021. Nevertheless, U.S. measles mortality had already fallen sharply from over 6,000 deaths in the early 1900s to fewer than 500 by the , reflecting broader improvements in , , and supportive medical care that reduced the case-fatality rate from around 1-2% to under 0.1% in developed settings before widespread . These trends highlight confounders in attributing all mortality reductions solely to vaccines, as parallel advancements mitigated disease severity independently.

Critiques of Clinical Trials, Regulatory Processes, and Long-Term Studies

Vaccine skeptics have criticized the design of clinical trials for many , particularly noting insufficient durations to assess long-term and safety. For instance, in the Pfizer-BioNTech Phase 3 trial, the primary analysis focused on confirmed cases beginning 7 days after the second dose, with safety data reported over a follow-up of 2 months, limiting insights into beyond initial periods. Similar short-term endpoints were used in other trials, raising concerns that waning immunity or delayed adverse effects could not be adequately captured. An additional methodological issue highlighted by skeptics involves the early unblinding and crossover of groups in trials. Once interim efficacy data demonstrated protection, ethical considerations prompted sponsors to unblind participants and offer the to recipients, effectively ending long-term -controlled comparisons and complicating assessments of relative risks over extended periods. This practice, while justified on humanitarian grounds, has been argued to preclude definitive data on versus no-intervention outcomes beyond the initial trial phase. Regulatory processes have drawn scrutiny for potentially diminishing incentives for rigorous safety oversight. The U.S. established a no-fault compensation program funded by an excise tax on , shielding manufacturers from most for injuries linked to defects, which skeptics contend reduces market-driven pressure to minimize risks. This framework, intended to stabilize supply amid prior litigation waves, has been criticized for fostering , where agencies like the FDA rely heavily on manufacturer-submitted data without independent verification of all manufacturing batches. Long-term studies on vaccine schedules face challenges due to the absence of large-scale randomized controlled trials (RCTs) evaluating cumulative effects. Childhood immunization schedules, comprising multiple administered in combinations, have not undergone comprehensive RCTs comparing fully vaccinated cohorts against unvaccinated controls, primarily due to ethical barriers against withholding standard care. Instead, and inferences rely on observational data, which skeptics argue are susceptible to —wherein vaccine recipients tend to be healthier or more health-conscious, confounding associations between vaccination and positive outcomes. This bias has been documented in studies of and vaccines, potentially inflating apparent benefits in real-world analyses. Proponents of skepticism, including independent researchers, maintain that such reliance on post-hoc undermines causal claims about schedule , advocating for inert placebo-controlled designs where feasible despite logistical hurdles.

Natural Immunity Versus Vaccine-Induced Protection

Natural immunity, acquired through recovery from , typically induces a multifaceted encompassing antibodies, memory B cells, and T cells targeting a wide array of antigens, as the host encounters the entire . In comparison, subunit or mRNA vaccines, such as those for , primarily stimulate responses against selected antigens like the , potentially limiting the breadth of cellular immunity to non-targeted epitopes. This broader exposure in natural fosters multispecific CD8+ T-cell responses in both lung tissue and peripheral blood, enhancing against viral variants. Empirical data on SARS-CoV-2 demonstrate that T-cell memory from natural infection persists with high cross-reactivity for at least two years, supporting durable protection against reinfection and severe outcomes.00255-0/fulltext) Natural cellular immunity, alone or combined with vaccination, confers stronger and longer-lasting defense compared to vaccination-induced responses, which show faster waning of neutralizing antibodies and narrower T-cell specificity. A 2022 cohort study of 52,238 Cleveland Clinic healthcare workers previously infected with SARS-CoV-2 found that additional mRNA vaccine boosters after initial infection did not further reduce COVID-19 incidence and were associated with higher infection risk per dose received, suggesting limited incremental benefit from vaccination atop natural immunity. Hybrid immunity—combining prior and —exhibits superior , with studies reporting 25- to 100-fold higher titers and enhanced neutralization against compared to either alone. For instance, hybrid immune individuals displayed lower rates and severe disease incidence than those with vaccine-only immunity, even against subvariants, underscoring the additive value of natural exposure's diverse epitopes.00633-3/fulltext)00287-7/fulltext) Historical precedents, such as varicella-zoster virus (VZV), illustrate similar dynamics: natural chickenpox infection elicits higher VZV-specific T-cell responses than vaccination, contributing to more robust long-term containment of viral latency. Community exposure to natural varicella cases boosts adult immunity via exogenous boosting, reducing herpes zoster (shingles) incidence; widespread vaccination disrupts this, potentially elevating short-term shingles rates until herd effects stabilize, as modeled in scenarios with over 35% vaccine coverage.

Notable Figures, Movements, and Organizations

Historical Anti-Vaccination Advocates

William Tebb, a pharmaceutical turned anti-vaccination activist, emerged as a key figure in the 1870s opposition to compulsory smallpox in . He documented perceived vaccine failures, including cases of post-vaccination deaths and disease transmission, through publications such as Compulsory Vaccination in England (1884), which compiled vital statistics and eyewitness accounts challenging the efficacy and safety of calf lymph vaccination. Tebb's work highlighted the Leicester experiment, where from the 1870s onward, widespread refusal of vaccination—prompted by the 1871 Vaccination Act's enforcement—coincided with a public health approach emphasizing , , and notification, reportedly yielding lower smallpox mortality rates than in high-vaccination areas during the 1871–1872 . His 1879 visit to the inspired the formation of the Anti-Vaccination Society of America, spreading arguments against state-mandated based on observed adverse events and correlations between vaccination coverage and disease persistence. In the United States, Lora C. Little advocated against compulsory in the late 19th and early 20th centuries, emphasizing vital statistics that, in her view, demonstrated and hygiene as superior preventives to vaccines for diseases like . She argued that violated individual rights, drawing on data from unvaccinated populations showing declining mortality independent of rates. Little's peaked in 1906 during Pennsylvania's outbreak, where she lectured and distributed literature asserting that vaccine-related injuries and inefficacy justified resistance, positioning reforms as the causal factor in epidemiological improvements. In 1914, she ran for the on a platform explicitly opposing mandates, framing them as medically unsubstantiated impositions on personal . Alfred Russel Wallace, the co-discoverer of , contributed intellectual weight to 19th-century skepticism through statistical critiques of data. In works like Vaccination a Delusion (1885), he analyzed English and Welsh records from 1850 to 1880, claiming that smallpox mortality rose with increasing enforcement, attributing declines to advancements rather than vaccines, and citing instances of vaccinated individuals contracting severe cases as evidence of incomplete protection. Wallace's first-principles approach questioned the causal link between and eradication, arguing that empirical trends favored environmental interventions over biological ones for gains. These advocates collectively prioritized observable data on adverse outcomes and alternative measures, influencing early organized resistance despite prevailing pro-vaccination narratives from medical authorities.

Modern Skeptic Leaders and Influencers

, a struck off the medical register in 2010 by the General Medical Council for ethical violations and professional misconduct related to his 1998 study, persisted in linking vaccines to through advocacy on the gut-brain axis hypothesis. He maintained that measles virus persistence in the gut, potentially from vaccines, contributes to regressive via inflammatory pathways affecting brain development, as explored in subsequent claims and the 2016 documentary he co-produced. Wakefield advocated separating , , and vaccines into single shots to mitigate alleged risks of the combined MMR formulation, influencing parental decisions despite large-scale epidemiological studies finding no causal association. Robert F. Kennedy Jr., founder of , elevated vaccine skepticism with his July 2005 article "Deadly Immunity," published concurrently in and , which accused government and pharmaceutical entities of concealing thimerosal—a mercury-containing preservative in vaccines—as a cause of autism epidemics. The piece prompted congressional hearings and contributed to thimerosal's phase-out from most U.S. childhood vaccines by 2001, though multiple Institute of Medicine reviews and cohort studies, including a 2010 CDC analysis of over 1,000 children, rejected any autism link. In June 2025, as U.S. Health and Human Services Secretary, Kennedy directed the removal of all 17 members of the CDC's Advisory Committee on Immunization Practices (ACIP), citing eroded public trust, and appointed replacements emphasizing transparency and alternative viewpoints on vaccine schedules. Joseph Mercola, an osteopathic operating Mercola.com since , has shaped alternative health narratives by questioning ingredients like aluminum adjuvants and mRNA platforms, often citing observational data on adverse events while promoting supplements as immune boosters. Labeled a primary figure in the "Disinformation Dozen" by for Countering Digital Hate—a group—for allegedly driving 65% of anti- content during the , Mercola's output includes newsletters and books like The Truth About COVID-19 (2021), which critiqued emergency authorizations based on short-term trial data. Other 21st-century influencers include , a former who directed and hosts the HighWire show, amplifying debates on vaccine surveillance systems like VAERS through interviews with skeptics. Tech entrepreneur , initially funding COVID-19 treatment trials, transitioned to critiquing mRNA vaccines in the 2020s, analyzing self-reported surveys claiming excess mortality correlations with vaccination rates in datasets from 2021–2023.

Grassroots and Advocacy Groups

The (NVIC), founded in 1982 by parents reporting injuries from the diphtheria-pertussis-tetanus (, operates as a nonprofit dedicated to public education on risks and for protections. It maintains databases of personal accounts from individuals claiming -related adverse events and promotes legislative efforts to expand exemptions from school mandates. NVIC emphasizes transparency in surveillance systems like the (VAERS), arguing that underreporting limits causal assessments of potential harms. Children's Health Defense (CHD), rebranded in 2018 from the earlier World Mercury Project initiative focused on environmental toxins, litigates against vaccine mandates and seeks disclosure of regulatory data on safety. The funds analyses of ingredients and epidemiological studies questioning correlations between vaccination schedules and chronic conditions in children. CHD has pursued federal lawsuits, including challenges to emergency use authorizations and claims of suppressed data on post-vaccination risks. Post-COVID-19, international networks such as the (ICAN), established in 2016, have mobilized through Act requests and legal actions against agencies like the for unredacted vaccine trial data and WHO-influenced policies. Similarly, the , a global coalition of health professionals and advocates formed during the pandemic, coordinates petitions opposing rollouts and critiques centralized pandemic treaty proposals for eroding national sovereignty over health choices. These groups facilitate cross-border sharing of reports and host webinars dissecting regulatory shortcuts in vaccine approvals.

Societal Impacts and Public Health Outcomes

In the United States, vaccination coverage among kindergarteners for key vaccines such as , , and (MMR) and , , and acellular pertussis (DTaP) stood at approximately 95% during the 2019–2020 school year prior to widespread disruptions. By the 2023–2024 school year, coverage had declined to 92.7% for MMR and 92.3% for DTaP, marking the first time rates fell below the 93% threshold for multiple vaccines. Exemptions from one or more required vaccines rose from 2.5% in 2019–2020 to 3.3% in 2023–2024 and further to a record 3.6% in the 2024–2025 school year, affecting over 138,000 incoming kindergartners. Non-medical exemptions, including philosophical and religious types, drove much of this increase, with 17 states reporting rates exceeding 5% in 2024–2025 compared to nine states pre-pandemic. These trends coincide with surveys documenting heightened parental skepticism toward routine childhood vaccines following COVID-19 vaccine rollouts and mandates. A 2022 survey of U.S. parents found 11% viewed childhood vaccines as less safe than before the pandemic, while broader hesitancy metrics from 2019–2022 showed increases among parents of school-aged children. Exemption approvals have accelerated in states with permissive policies, contributing to uneven coverage; for instance, medical exemptions remained stable at around 0.2%, underscoring the role of non-medical opt-outs in the overall rise. Globally, childhood coverage has stagnated post-pandemic, with 14.3 million infants classified as zero-dose—having received no vaccines—in 2024, exceeding the 2019 baseline of 12.8 million despite efforts to recover. First-dose coverage for diphtheria-tetanus-pertussis (DTP) vaccines reached 89% among infants in 2024, but full-series completion lags, particularly in low-income regions where hesitancy intersects with access barriers. This persistence of zero-dose children reflects broader trends amplified by misinformation and pandemic-era distrust, though data indicate slow rebounds in some high-burden countries.

Associations with Disease Outbreaks and Incidence

In 2019, the experienced its largest measles outbreak since 1992, with 1,282 confirmed cases reported by the Centers for Disease Control and Prevention (CDC), predominantly among unvaccinated individuals or those with unknown vaccination status in close-knit communities with low rates, such as Jewish populations in . These clusters highlighted localized correlations between and outbreak initiation, as imported cases from abroad spread rapidly in under-vaccinated pockets where thresholds (typically 95% coverage for ) were not met. However, the outbreak resulted in no fatalities in the U.S., contrasting sharply with the pre-vaccine era when caused an estimated 3–4 million infections annually and 400–500 deaths. Resurgences of pertussis (whooping cough) provide evidence of disease incidence linked not solely to hesitancy but also to limitations in vaccine-induced immunity. In 2012, Washington State reported over 4,700 cases during an epidemic—the highest since the 1940s—despite vaccination coverage exceeding 90% in many areas, with cases occurring disproportionately among adolescents and adults whose acellular pertussis vaccine protection had waned after 2–4 years. Nationwide, the U.S. saw approximately 48,277 pertussis cases that year, a resurgence attributed in peer-reviewed analyses to the switch from whole-cell to acellular vaccines in the 1990s, which offered shorter-term efficacy and allowed asymptomatic transmission in vaccinated carriers, rather than primarily unvaccinated populations. This pattern underscores causal factors beyond hesitancy, including vaccine design flaws that enable outbreaks in highly immunized groups. Debates over excess mortality illustrate contested associations between high rates and all-cause death trends. Vaccine skeptics have cited sustained excess deaths in Western countries post-2021 rollout—totaling over 3 million across 47 nations through 2022, with rates remaining elevated at 7–10% above baseline despite widespread —as potential signals of vaccine-related harms, including and immune dysregulation, amid correlations with booster campaigns. Peer-reviewed analyses from and other high- settings have documented spikes in all-cause mortality following repeated mRNA doses, hypothesizing contributions from adverse events, though remains unproven and confounded by factors like prior waves and healthcare disruptions. Counterarguments from authorities, such as Norwegian registry data, report lower mortality among vaccinated cohorts during 2021–2023, attributing excesses primarily to unmitigated viral circulation rather than vaccines, while acknowledging reporting biases in undercounted non-COVID deaths. These divergences reflect challenges in disentangling vaccine effects from multifactorial drivers in observational data.

Economic and Policy Consequences

Vaccine skepticism has led to reduced demand for boosters and updated formulations, resulting in significant revenue shortfalls for major pharmaceutical companies. In January 2025, slashed its full-year sales forecast by $1 billion, primarily due to weak uptake of its amid broader hesitancy. By 2025, the company further revised its 2025 revenue guidance downward to $1.5 billion to $2.2 billion, reflecting a projected 32% decline from prior-year levels and contributing to eroded market value for biotech investors. Pfizer's 2025 revenue outlook, while broader at $61 billion to $64 billion including COVID products, has similarly faced pressures from declining booster sales, with industry analysts linking the trend to sustained public doubts over long-term efficacy and safety data. These economic effects extend to broader biopharma challenges, as regulatory adjustments responsive to —such as stricter FDA approval pathways—have anticipated further drops in rates and associated earnings. Policy responses at the federal level have reinforced exemptions, influencing state-level governance. In September 2025, the U.S. Department of Health and (HHS) issued guidance affirming that healthcare providers must honor state laws protecting religious and conscience-based exemptions from mandates, signaling a pivot toward prioritizing individual rights over uniform compliance. School mandate challenges have accelerated, with legal victories expanding parental options. In July 2025, a court granted religious exemptions to children of suing parents, upholding challenges to longstanding mandates and prompting over 300 exemptions under a newly laxer policy by late 2025. Nationally, nonmedical exemptions for school entry reached a record 4.1% in the 2024-2025 , correlating with falling childhood rates and prompting legislative expansions in multiple states to accommodate philosophical and religious objections. These shifts have reduced administrative enforcement costs for agencies but increased scrutiny on exemption verification processes.

Responses, Counterarguments, and Ongoing Controversies

Official Rebuttals and Fact-Checking Efforts

Following the retraction of Andrew Wakefield's 1998 paper in 2010, the U.S. Centers for Disease Control and Prevention (CDC) launched public statements and resources asserting no causal link between the MMR vaccine and autism spectrum disorder (ASD), referencing epidemiological evidence from cohort and case-control studies involving over 1.2 million children. Similarly, the World Health Organization (WHO) emphasized vaccine safety in global communications, citing systematic reviews that found no increased ASD risk post-vaccination. These efforts drew on meta-analyses, such as the 2014 Taylor et al. review in Vaccine, which pooled data from five cohort studies (1,256,407 children) and five case-control studies (9,920 children), yielding odds ratios near 1.0 (e.g., OR 0.91 for ASD overall, 95% CI 0.68-1.20), indicating no association. Official rebuttals extended to platforms partnered with health agencies; for instance, the CDC collaborated with sites like to debunk claims of vaccine-induced , often highlighting flaws in retracted studies like Wakefield's, which involved undeclared conflicts and ethical violations. During the , agencies amplified these through campaigns like the CDC's "Vaccines Do Not Cause " page, updated as of December 2024, which aggregates evidence from Danish cohorts (657,461 children) showing MMR-vaccinated children had lower rates (HR 0.93, 95% CI 0.85-1.02). WHO's Agenda 2030 similarly counters by promoting evidence-based narratives on safety. Social media platforms implemented moderation in 2021, with and pre-Musk (now X) flagging or removing content alleging vaccines caused infertility or widespread deaths, in coordination with WHO and CDC definitions of ; reported deleting millions of such posts, reducing visibility by up to 90% via algorithmic demotion. These policies aimed to curb hesitancy, citing studies linking exposure to 6-13% lower intent. However, vaccine skeptics critiqued these efforts as overreach, arguing that moderation suppressed legitimate questions about rare adverse events (e.g., myocarditis signals in VAERS data, with rates of 1-10 per 100,000 doses in young males), and that observational studies fail to establish due to confounders like genetic predispositions or underreporting in passive surveillance systems. By 2025, policy reversals emerged under new U.S. leadership, with the CDC announcing a study in March to re-examine -autism links despite prior meta-analyses, amid outbreaks tied to hesitancy; a skeptic was appointed to lead aspects of research. Concurrently, discontinued its third-party program in January, citing it as prior "censorship," potentially allowing broader dissemination of skeptical claims while raising concerns among experts about unchecked resurgence. Skeptics welcomed these shifts, contending that institutional often dismissed empirical gaps, such as the CDC's 2004 DeStefano study allegedly omitting subgroup analyses showing higher risk in African American boys (per 2014 whistleblower claims by William Thompson), though subsequent reviews found no overall bias in the data. These developments highlight ongoing tensions between precautionary empirical scrutiny and consensus-driven rebuttals. ![NIHR Infographic on vaccine misinformation][float-right] In (1905), the U.S. upheld a state law authorizing compulsory smallpox during outbreaks, ruling that individual liberty yields to reasonable measures, provided they include procedural safeguards like fines rather than forcible administration. This precedent established states' police powers for mandates but was tested during the era, where federal courts issued numerous injunctions against mandates, including the Supreme Court's 2022 decision blocking the OSHA rule requiring vaccination or testing for large employers due to overreach beyond workplace safety. Lower courts also granted temporary stays on mandates for federal contractors and healthcare workers, citing procedural flaws and equitable arguments like prior infection conferring immunity, though natural immunity was more often addressed in policy exemptions than binding rulings. From 2024 onward, vaccine skepticism influenced U.S. policy reversals, particularly after the 2024 election. In August 2025, HHS Secretary directed the termination of 22 development projects under BARDA, totaling nearly $500 million, based on a review concluding that such vaccines demonstrated insufficient protection against respiratory viruses and elevated risks relative to benefits. , a prominent skeptic appointed to lead HHS, also oversaw shifts excluding vaccines from routine recommendations for healthy children and pregnant women, prioritizing data on long-term efficacy and adverse events over prior universal endorsements. State-level changes accelerated, with announcing in September 2025 the elimination of all state mandates, including requirements, to emphasize parental amid debates over mandate . Internationally, courts have increasingly recognized injury claims, prompting compensation precedents. In the , the Court of Justice's February 2025 ruling in case C-586/23 P affirmed physicians' discretion in prescribing vaccines, potentially exposing prescribers to liability for uninformed administration and underscoring obligations. Earlier, national courts in member states awarded compensations for adverse events; for instance, Danish and Irish rulings from 2023 upheld claims linking to chronic conditions like and CRPS, rejecting manufacturer defenses and mandating payouts under no-fault schemes after evidence of underreported risks emerged in data. These decisions, influenced by skeptic-led petitions, have expanded eligibility for injury funds, contrasting with pre-2020 denials and highlighting causal links via temporal associations and biological plausibility in peer-reviewed analyses. Vaccine skeptics argue that requires full disclosure of potential adverse events, emphasizing the U.S. (NVICP), established under the 1986 , which has awarded over $5.2 billion in compensation for vaccine-related injuries and deaths since 1988, thereby acknowledging inherent risks that individuals must weigh autonomously. This perspective holds that mandates undermine personal sovereignty, as coercion bypasses voluntary assessment of individual risk-benefit profiles, potentially eroding in health authorities when rare but severe outcomes occur despite assurances of safety. Proponents of mandates counter that high vaccination coverage is essential for , which for requires approximately 95% population immunity to interrupt transmission chains and protect vulnerable groups unable to vaccinate, such as infants or immunocompromised individuals. They contend that individual refusals, even if based on , impose externalities like outbreak risks, justifying limited overrides of for collective welfare, as evidenced by legal precedents upholding school-entry requirements to sustain population-level protection. Post-COVID-19 surveys highlight shifting perceptions fueling advocacy, with a January 2025 Kaiser Family Foundation (KFF) tracking poll finding that 25% of U.S. parents of children under 18 believe the risks of the outweigh its benefits, up from prior years and linked to heightened scrutiny of vaccine safety data. Skeptics invoke first-principles assessments of disease severity in resource-rich settings, noting interventions like supplementation can reduce mortality by up to 50% in deficient children through supportive care, suggesting modern lethality is lower than historical baselines and thus warranting individualized rather than blanket mandates. This contrasts with mandate advocates' focus on vaccines' role in averting complications, though critics argue such policies incur social costs like family separations or eroded without proportionally addressing tailored risk factors.

References

  1. [1]
    History of Anti-Vaccination Movements - HistoryOfVaccines.org
    Critics of vaccination have taken various positions, including opposition to the smallpox vaccine in England and the United States in the mid to late 1800s.
  2. [2]
    Review of adverse events associated with COVID-19 vaccines ...
    Rare adverse effects of COVID-19 vaccines include anaphylaxis, blood clots, myocarditis, pericarditis, hearing changes, and tinnitus.
  3. [3]
    COVID-19 vaccines and adverse events of special interest
    Apr 2, 2024 · This study aimed to evaluate the risk of adverse events of special interest (AESI) following COVID-19 vaccination from 10 sites across eight countries.
  4. [4]
    a deep dive into vaccine adverse event reporting system data
    This study analyzed the Vaccine Adverse Event Reporting System (VAERS) data from 2020–2022 using statistical methods such as zero-truncated Poisson regression ...
  5. [5]
    Serious adverse events following immunization with COVID-19 ...
    Oct 21, 2024 · The most prevalent AEFIs were vascular disorders (37%), followed by cardiac (25%) and nervous system disorders (14%). The adverse events were ...
  6. [6]
    Edward Jenner and the history of smallpox and vaccination - NIH
    There were concerns that recipients might develop disseminated smallpox and spread it to others. Transmission of other diseases, such as syphilis, via the ...
  7. [7]
    Smallpox Vaccine: The Good, the Bad, and the Ugly - PMC
    Edward Jenner of Gloucestershire, England noticed that milkmaids exposed to cowpox appeared to be immune to smallpox.
  8. [8]
    Victorian Health Reform - The National Archives
    A formal pressure group, the Anti-Vaccination League, formed in London after the Act of 1853. Later the Anti-Compulsory Vaccination League was founded in 1867 ...
  9. [9]
    Anti-vaccinationists past and present - PMC - NIH
    The Anti-Compulsory Vaccination League was founded in 1867 in response to the new law, with a seven point mission statement on the masthead of its newsletter, ...
  10. [10]
    The anti-vaccination movement that gripped Victorian England - BBC
    Dec 27, 2019 · In the late 19th Century, tens of thousands of people took to the streets in opposition to compulsory smallpox vaccinations. There were arrests, ...Missing: adverse events
  11. [11]
    Leicester : sanitation versus vaccination
    — Leicester Small-Pox Epidemics. The Epidemic of 1892-94 and Dr. Priestley ... materially enhanced the success of the anti- vaccination movement. Respecting ...
  12. [12]
    The Cutter Incident: How America's First Polio Vaccine Led to ... - NIH
    Within days there were reports of paralysis and within a month the first mass vaccination programme against polio had to be abandoned.
  13. [13]
    Executive Summary - Adverse Events Associated with Childhood ...
    Concern over the safety of pretties vaccine was long-standing in Great Britain by the time of the 1982 airing in the United States of a documentary entitled " ...Missing: moratorium | Show results with:moratorium
  14. [14]
    TV report on DTP galvanizes US pediatricians - PubMed
    An NBC television documentary on the risks of the diphtheria-pertussis-tetanus (DPT) vaccine, aired in April 1982, alarmed parents and elicited criticism from ...Missing: encephalopathy concerns 1970s 1980s moratorium
  15. [15]
    History of Pertussis Vaccine
    Feb 18, 2023 · In 1982, the damaging effects of the highly reactive DPT vaccine was profiled in an award-winning television documentary DPT: Vaccine Roulette.Missing: moratorium | Show results with:moratorium
  16. [16]
    Vaccine Injury Compensation Programs - HistoryOfVaccines.org
    In 1955, about 200 people were paralyzed and ten died after contracting polio ... Vaccine for Children program, and regulatory issues. The NVICP provides ...
  17. [17]
    History of NCNM: The Mothership @ 60 - NUNM
    Mar 7, 2017 · In the fall of 1956, five students and a group of determined naturopathic doctors set out to start a school and save a profession.
  18. [18]
    DP18109 The Deep Roots of Vaccine Hesitancy in Germany - CEPR
    Apr 24, 2023 · This paper studies the historical roots of vaccine hesitancy in the context of Germany. Using digitized data on the existence of naturopathic ...Missing: postwar skepticism parental rights
  19. [19]
    The MMR vaccine and autism: Sensation, refutation, retraction ... - NIH
    In 1998, Andrew Wakefield and 12 of his colleagues[1] published a case series in the Lancet, which suggested that the measles, mumps, and rubella (MMR) ...
  20. [20]
    A timeline of the Wakefield retraction | Nature Medicine
    28 February 1998 Gastroenterologist Andrew Wakefield reports in The Lancet that his team has found a “genuinely new syndrome”—a link between the measles, mumps ...
  21. [21]
    MMR Vaccine Attitude and Uptake Research in the United Kingdom
    However, MMR uptake has seen some disturbances in the mid-2010s, and the UK lost its elimination status following a large 2018 outbreak of 913 confirmed cases ...
  22. [22]
    Developmental regression and autism reported to the Vaccine ...
    We report demographic and clinical characteristics of children reported to the US Vaccine Adverse Event Reporting System (VAERS) as having autism or another ...
  23. [23]
    Wakefield's article linking MMR vaccine and autism was fraudulent
    Jan 6, 2011 · The 1998 Lancet paper that implied a link between the measles, mumps, and rubella (MMR) vaccine and a “new syndrome” of autism and bowel disease.Errata - March 15, 2011 · All rapid responses · Peer review<|separator|>
  24. [24]
    Lancet retracts 12-year-old article linking autism to MMR vaccines
    Feb 2, 2025 · Twelve years after publishing a landmark study that turned tens of thousands of parents around the world against the measles, mumps and rubella (MMR) vaccine
  25. [25]
    A Population-Based Study of Measles, Mumps, and Rubella ...
    This study provides strong evidence against the hypothesis that MMR vaccination causes autism. It has been suggested that the measles, mumps, and rubella (MMR) ...
  26. [26]
    A population-based study of measles, mumps, and rubella ... - PubMed
    This study provides strong evidence against the hypothesis that MMR vaccination causes autism.Missing: 537000 | Show results with:537000
  27. [27]
    MMR vaccine is not linked with autism, says Danish study - PMC
    A Danish study of more than half a million children showed no link between measles, mumps, and rubella (MMR) vaccination and autism.Missing: 537000 | Show results with:537000
  28. [28]
    Vaccine Adverse Event Reporting System 1990–2001 - PMC - NIH
    Objectives. We investigated vaccine risk perception among reporters of autism to the Vaccine Adverse Event Reporting System (VAERS). Methods.
  29. [29]
    Measles in the United Kingdom 1990–2008 and the effectiveness of ...
    Uptake of measles, mumps and rubella (MMR) vaccine is currently suboptimal in the UK, with only 83% of 5-year-olds adequately immunised in line with the ...
  30. [30]
    Measles outbreaks in the UK, is it when and where, rather than if? A ...
    There was a large outbreak of measles in Liverpool, UK, in 2012–2013, despite measles, mumps and rubella (MMR) immunisation uptake rates that were higher than ...
  31. [31]
    Why Parents Say No to Having Their Children Vaccinated against ...
    Vaccine hesitancy to MMR and other childhood vaccines clustered in middle- to high-income areas among mothers with a college-level education or higher who ...
  32. [32]
    First COVID-19 Vaccines Receiving the US FDA and EMA ... - NIH
    The first vaccine receiving emergency authorization by the FDA on December 11, 2020, and by the EMA on December 21, 2020, is the mRNA-based vaccine Comirnaty ...
  33. [33]
    Myocarditis following COVID‐19 vaccine - PubMed Central - NIH
    Male adolescents (age 16–17 years) had the highest incidence of myocarditis (75.9 per million doses administered) after receiving the second dose of an mRNA ...
  34. [34]
    VAERS - Data - HHS.gov
    May 8, 2025 · Search data with an easy-to-use, menu-driven tool. Produce tables, maps, charts, and data extracts of vaccine adverse events. Search CDC Wonder.Guide to Interpreting VAERS... · Data Sets · ResourcesMissing: excess | Show results with:excess
  35. [35]
    Twelve-Month All-Cause Mortality after Initial COVID-19 Vaccination ...
    Apr 29, 2025 · Twelve-Month All-Cause Mortality after Initial COVID-19 Vaccination with Pfizer-BioNTech or mRNA-1273 among Adults Living in Florida. Retsef ...Missing: FOIA documents
  36. [36]
    Excess mortality across countries in the Western World since the ...
    In 2022, when most containment measures were lifted and COVID-19 vaccines were continued, preliminary data present 808 392 excess deaths (P-score 8.8%).
  37. [37]
    HHS Winds Down mRNA Vaccine Development Under BARDA
    Aug 5, 2025 · The decision follows a comprehensive review of mRNA-related investments initiated during the COVID-19 public health emergency. “We reviewed the ...
  38. [38]
    RFK Jr. slashes $500M from vaccine research - POLITICO
    Aug 6, 2025 · Health Secretary Robert F. Kennedy Jr. pulled the plug Tuesday on half a billion dollars of vaccine research.Missing: studies | Show results with:studies
  39. [39]
    Vaccination Coverage and Exemptions among Kindergartners - CDC
    Jul 31, 2025 · During the 2024-2025 school year, exemptions from one or more vaccines among kindergartners in the U.S. increased to 3.6% from 3.3% the year ...
  40. [40]
    Rise of vaccine distrust - why more of us are questioning jabs - BBC
    Jan 15, 2025 · Confidence in all types of vaccination has taken a hit. The question is why, and what can be done about it?
  41. [41]
    Swine Influenza Vaccine and Guillain-Barré Syndrome: Epidemic or ...
    The (A-New Jersey-76) swine influenza vaccine administered to 45 million persons in the United States between Oct 1 and Dec 16,1976, was causally associated ...
  42. [42]
    Guillain-Barre syndrome following vaccination in the National ...
    This surveillance uncovered a total of 1098 patients with onset of GBS from October 1, 1976, to January 31, 1977, from all 50 states, District of Columbia, and ...
  43. [43]
    Rotavirus vaccine withdrawal in the United States - PubMed Central
    By the beginning of October 1999, 101 confirmed and presumed cases of intussusception had been reported to VAERS. The rate of reporting increased greatly after ...
  44. [44]
    Suspension of Rotavirus Vaccine After Reports of Intussusception
    Sep 3, 2004 · No cases of RRV-TV--associated intussusception occurred in infants and children vaccinated after July 16, 1999. When the VAERS findings were ...
  45. [45]
    [PDF] r18hs017045-lazarus-final-report-2011.pdf
    Dec 1, 2007 · Performing Organization: Harvard Pilgrim Health Care, Inc. Project Officer: Steve Bernstein. Submitted to: The Agency for Healthcare Research ...Missing: factor | Show results with:factor
  46. [46]
    Vaccine-induced autoimmunity: the role of molecular mimicry and ...
    In this review, we address the concept of molecular mimicry and its application in explaining post vaccination autoimmune phenomena.Missing: peer | Show results with:peer
  47. [47]
    Potential clinical implications of molecular mimicry‐induced ...
    Feb 1, 2024 · The concept of molecular mimicry has significant clinical implications if proven to be a major mechanism underlying autoimmunity.
  48. [48]
    Analysis of health outcomes in vaccinated and unvaccinated children
    May 27, 2020 · The aim of this study was to compare the health of vaccinated versus unvaccinated pediatric populations. Using data from three medical ...
  49. [49]
    Effectiveness of pertussis vaccination and duration of immunity - PMC
    We observed high effectiveness of the pertussis vaccine within 3 years of vaccination, but with clear evidence of waning of immunity beyond 4 years and little- ...
  50. [50]
    What Is Wrong with Pertussis Vaccine Immunity? The Problem ... - NIH
    Acellular pertussis vaccines provide protection during the first years of life, but their effectiveness wanes a few years post-boosters.
  51. [51]
    California pertussis epidemic, 2010 - PubMed
    Most pediatric cases were vaccinated according to national recommendations, although 9% of those aged 6 months to 18 years were completely unvaccinated against ...
  52. [52]
    California Pertussis Epidemic 2010: A Review of 986 Pediatric Case ...
    Mar 1, 2012 · The California Department of Public Health (CDPH) declared a pertussis epidemic on 23 June 2010. More cases were reported in 2010 (9146) than in ...Missing: teens | Show results with:teens
  53. [53]
    Waning and Less Effective Acellular Whooping Cough Vaccines ...
    Oct 22, 2011 · In 2010 California experienced the highest rate of whooping cough (pertussis) in over 50 years. This increase comes after decades of gradually ...Missing: epidemic teens<|separator|>
  54. [54]
    An observational study of breakthrough SARS-CoV-2 Delta variant ...
    Breakthrough Delta variant infections following Oxford-AstraZeneca vaccination may cause asymptomatic or mild disease, but are associated with high viral loads, ...
  55. [55]
    Viral loads of Delta-variant SARS-CoV-2 breakthrough infections ...
    Nov 2, 2021 · The effectiveness of the coronavirus disease 2019 (COVID-19) BNT162b2 vaccine in preventing disease and reducing viral loads of breakthrough ...
  56. [56]
    Confronting the Delta Variant of SARS-CoV-2, Summer 2021
    Aug 18, 2021 · This Viewpoint discusses the Delta variant of SARS-CoV-2, including its epidemiology, transmissibility, how uneven vaccination coverage in ...
  57. [57]
    Protection and Waning of Natural and Hybrid Immunity to SARS-CoV-2
    May 25, 2022 · Recent studies have shown waning of the immunity provided by the BNT162b2 vaccine. The time course of natural and hybrid immunity is unknown.Missing: superior | Show results with:superior
  58. [58]
    Comparing SARS-CoV-2 natural immunity to vaccine-induced ...
    Aug 25, 2021 · This study demonstrated that natural immunity confers longer lasting and stronger protection against infection, symptomatic disease and hospitalization
  59. [59]
    Comparing COVID-19-related hospitalization rates among ... - Nature
    Apr 22, 2022 · We demonstrate that infection-induced immunity (enhanced or not) provides more protection against COVID-19-related hospitalization than non-recent vaccine ...
  60. [60]
    Protection from previous natural infection compared with mRNA ...
    Nov 11, 2022 · Vaccine protection against infection waned with time after the second dose, whereas natural immunity showed little waning in protection for at ...
  61. [61]
    Having SARS-CoV-2 once confers much greater immunity ... - Science
    Aug 26, 2021 · Israelis who had an infection were more protected against the Delta coronavirus variant than those who had an already highly effective COVID-19 ...
  62. [62]
    Non-linear dose-response of aluminium hydroxide adjuvant particles
    Jan 15, 2017 · We conclude that Alhydrogel injected at low dose in mouse muscle may selectively induce long-term Al cerebral accumulation and neurotoxic effects.Missing: studies | Show results with:studies<|separator|>
  63. [63]
    Biopersistence and Brain Translocation of Aluminum Adjuvants of ...
    Alum-containing vaccines may also induce skin pseudo-lymphoma in humans (41), and fibrosarcoma in cats (42). Macrophagic myofasciitis has been reproduced ...
  64. [64]
    Macrophagic myofasciitis lesions assess long-term persistence of ...
    Using 26Al-labelled adjuvants, Flarend and colleagues showed that 17% of a full human dose of aluminium hydroxide, and 51% of a similar dose of aluminium ...
  65. [65]
    Aluminum vaccine adjuvants: are they safe? - PubMed
    In particular, aluminum in adjuvant form carries a risk for autoimmunity, long-term brain inflammation and associated neurological complications and may thus ...Missing: animal | Show results with:animal
  66. [66]
    Thimerosal and Vaccines - CDC
    Methylmercury is the type of mercury found in certain kinds of fish. At high exposure levels methylmercury can be toxic to people. In the United States, federal ...Missing: pre- | Show results with:pre-
  67. [67]
    Thimerosal exposure in infants and neurodevelopmental disorders
    In the last few decades, vaccines—one of the greatest breakthroughs in health sciences—have helped to accomplish striking reductions of infection and disease ...
  68. [68]
    Thimerosal-Containing Vaccines and Neurodevelopmental Disorders
    Immunization to protect infants and children from vaccine-preventable diseases is one of the greatest achievements in public health. The use of vaccines is ...
  69. [69]
    Thimerosal-Containing Vaccines and Autism: A Review of Recent ...
    Certain fish contain methylmercury, and ethylmercury is a component of thimerosal used in vaccines. Although these 2 organic forms of mercury are related, they ...
  70. [70]
    Immunization Safety Review: SV40 Contamination of Polio Vaccine ...
    IPV administered between 1955 and 1963 to about 98 million children and adults is assumed to be the primary source of human exposure to SV40 in the United ...
  71. [71]
    Executive Summary - Immunization Safety Review - NCBI Bookshelf
    Some of the polio vaccine administered from 1955–1963 was contaminated with a virus, called simian virus 40 (SV40). The virus came from the monkey kidney cell ...
  72. [72]
    Batch‐dependent safety of the BNT162b2 mRNA COVID‐19 vaccine
    Mar 30, 2023 · We therefore examined rates of SAEs between different BNT162b2 vaccine batches administered in Denmark (population 5.8 million) from 27 December 2020 to 11 ...Missing: peer- | Show results with:peer-
  73. [73]
    Safety of BNT162b2 mRNA COVID-19 Vaccine Batches - PubMed
    The findings support the overall safety of the vaccine, with no clinically relevant variations in serious adverse event rates between batches.Missing: peer- reviewed
  74. [74]
    Human Cell Strains in Vaccine Development - HistoryOfVaccines.org
    Groups that object to abortion have raised ethical questions about Plotkin's rubella vaccine (and other vaccines developed with similar human cell strains) over ...Missing: COVID | Show results with:COVID
  75. [75]
    Vaccine Ingredients: Fetal Cells - Children's Hospital of Philadelphia
    Jan 16, 2024 · The fetal fibroblast cells used to grow vaccine viruses were first obtained from elective termination of two pregnancies in the early 1960s.Missing: ethical | Show results with:ethical
  76. [76]
    Helping patients with ethical concerns about COVID-19 vaccines in ...
    Many persons with religious convictions report hesitancy about COVID-19 vaccines, in part due to ethical concerns that fetal cell lines are used in the ...Missing: rubella | Show results with:rubella
  77. [77]
    The Nuremberg Code | Holocaust Encyclopedia
    1. The voluntary consent of the human subject is absolutely essential. · 2. The experiment should be such as to yield fruitful results for the good of society, ...
  78. [78]
    The Case against compulsory vaccination - Journal of Medical Ethics
    Arguments for mandatory or compulsory vaccination must justify the coercive infringement of bodily integrity via the injection of chemicals that permanently ...
  79. [79]
    Age-specific measles mortality during the late 19th–early 20th ... - NIH
    Measles mortality fell markedly (>90%) from the 19th century to mid-20th century prior to introduction of measles vaccine or the widespread use of antibiotics ...
  80. [80]
    The unintended consequences of COVID-19 vaccine policy
    May 26, 2022 · We argue that current mandatory vaccine policies are scientifically questionable and are likely to cause more societal harm than good.
  81. [81]
    Hearing Wrap Up: COVID-19 Vaccine Mandates Sacrificed ...
    Jul 28, 2023 · The lost wages and sacrifices made by families like mine who stood up to the overreaching, unjustified mandates to preserve their autonomy and ...
  82. [82]
    Global vaccine market report 2024 - World Health Organization (WHO)
    Dec 19, 2024 · The 2024 GVMR provides a snapshot of vaccine markets globally in 2023, covering 88 vaccine products sold in 207 countries and procurement channels by 116 ...
  83. [83]
    About The Untreated Syphilis Study at Tuskegee - CDC
    Sep 4, 2024 · As part of the study, researchers did not collect informed consent from participants. They also did not offer treatment, even after it was ...Effects on Research · Timeline · Site Index
  84. [84]
    Preventing and Managing Adverse Reactions - CDC
    Jul 25, 2024 · ... anaphylaxis following vaccines is rare, occurring at a rate of approximately one per million doses for many vaccines5. Epinephrine and ...
  85. [85]
    Anaphylaxis after vaccination reported to the Vaccine Adverse Event ...
    The estimated rate of anaphylaxis reported to VAERS during 1990 to 2016 after MMR was 0.6 per 1 million doses distributed, and after pneumococcal polysaccharide ...
  86. [86]
    Allergic Reactions Including Anaphylaxis After Receipt of the ... - CDC
    Jan 15, 2021 · Twenty-one cases were determined to be anaphylaxis (a rate of 11.1 per million doses administered), including 17 in persons with a documented ...
  87. [87]
    Vaccines and sudden infant death: An analysis of the VAERS ...
    Of the 1048 SIDS cases, 51 % clustered within 3 days post-vaccination and 75.5 % within 7 days post-vaccination. The remaining SIDS cases occurred between 8 ...
  88. [88]
    Reaffirming a Positive Correlation Between Number of Vaccine ...
    Feb 2, 2023 · Of the 2605 infant deaths reported to the Vaccine Adverse Event Reporting System (VAERS) from 1990 through 2019, 58% clustered within three days ...<|separator|>
  89. [89]
    Yellow Card data isn't proof of Covid-19 vaccine deaths - Full Fact
    Aug 4, 2021 · This showed that there had been 1,517 yellow card reports of death around the time of Covid-19 vaccination.Missing: excess | Show results with:excess
  90. [90]
    COVID-19 Vaccines and Heavy Menstrual Bleeding - NIH
    Apr 12, 2024 · During the COVID-19 vaccination campaign, over 34,000 reports of heavy menstrual bleeding following the administration of COVID-19 vaccines ...Missing: disruptions | Show results with:disruptions
  91. [91]
    Association between COVID-19 Vaccines and Menstrual Disorders
    Aug 18, 2024 · In 2022, the European Medicines Agency (EMA) informed that the mRNA vaccines may be associated with the occurrence of menstrual disorders, ...Missing: disruptions | Show results with:disruptions
  92. [92]
    Menstrual disorders following COVID-19 vaccination: a review using ...
    Menstrual disorders are commonly reported after COVID-19 vaccination and heavy menstrual bleeding was added to the product information of the COVID-19 ...Introduction · Materials and methods · Results · Discussion
  93. [93]
    Meeting highlights from the Pharmacovigilance Risk Assessment ...
    Aug 6, 2021 · The PRAC discussed reported cases of menstrual disorders occurring after vaccination against COVID-19. No causal association between COVID ...Missing: disruptions | Show results with:disruptions
  94. [94]
    Vaccination Status and Health in Children and Adolescents
    Unvaccinated children aged 1–5 years had a median number of 3.3 (2.1–4.6) infectious diseases in the past year, compared to 4.2 (4.1–4.4) in vaccinated children ...
  95. [95]
    (PDF) Vaccination Status and Health in Children and Adolescents
    Aug 6, 2025 · PDF | Whether unvaccinated children and adolescents differ from those vaccinated in terms of health is subject to some discussion.
  96. [96]
    Smallpox - World Health Organization (WHO)
    The last known natural case was in Somalia in 1977. In 1980 WHO declared smallpox eradicated – the only infectious disease to achieve this distinction. This ...
  97. [97]
    Life and death of smallpox - ScienceDirect.com
    ... vaccination campaign led to the total eradication of smallpox in 1977. During that century, smallpox caused an estimated 300–500 million deaths worldwide.
  98. [98]
    The decline of adult smallpox in eighteenth-century London - PMC
    Smallpox mortality seems to have peaked in London in the 1760s, before declining slowly, and then rapidly after 1800 (both as a proportion of burials, and as ...
  99. [99]
    Poliomyelitis - World Health Organization (WHO)
    Apr 2, 2025 · Wild poliovirus cases have decreased by over 99% since 1988, from an estimated 350 000 cases in more than 125 endemic countries then, to two ...
  100. [100]
    From Emergence to Eradication: The Epidemiology of Poliomyelitis ...
    Although the evidence is ... Again, this suggests that gradual improvements in sanitation and hygiene reduced the circulation of enteric infections.
  101. [101]
    History of Measles - CDC
    May 9, 2024 · In the first decade of reporting, an average of 6,000 measles-related deaths were reported each year. A vaccine became available in 1963. In the ...
  102. [102]
    Measles - World Health Organization (WHO)
    Nov 14, 2024 · Measles is a highly contagious disease caused by a virus. It spreads easily when an infected person breathes, coughs or sneezes.Measles cases surge... · Measles and rubella strategic...<|separator|>
  103. [103]
    Rate of measles cases and deaths in the United States
    The reported annual rate of new cases and deaths from measles, per 100000 people in the population.
  104. [104]
    Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
    Dec 10, 2020 · A two-dose regimen of BNT162b2 conferred 95% protection against Covid-19 in persons 16 years of age or older. Safety over a median of 2 months was similar to ...
  105. [105]
    [PDF] Pfizer-BioNTech COVID-19 Vaccine VRBPAC Briefing Document
    Dec 10, 2020 · Primary Efficacy Endpoints. Study C4591001 has two primary endpoints: • First primary endpoint: COVID-19 incidence per 1000 person-years of ...<|separator|>
  106. [106]
    Ethical Considerations for Unblinding and Vaccinating COVID-19 ...
    We argue that, once proven efficacious, vaccine makers and researchers have an ethical obligation to unblind the placebo groups of COVID-19 vaccine trials and ...Missing: washout | Show results with:washout
  107. [107]
    Long-Term Studies Of COVID-19 Vaccines Hurt By Placebo ... - NPR
    Feb 19, 2021 · But clinical trials that include a placebo group are the surest and most definitive ways to gather information about vaccine effectiveness. "I ...Missing: washout | Show results with:washout
  108. [108]
    About the National Vaccine Injury Compensation Program - HRSA
    Sep 4, 2025 · The VICP is a no-fault program providing compensation for vaccine injuries, aiming to ensure vaccine supply, stabilize costs, and maintain an ...
  109. [109]
    The National Childhood Vaccine Injury Act and the Supreme Court's ...
    ... Vaccine Injury Act to mean that vaccine manufacturers, unlike the manufacturers of other products, are not liable for injuries caused by defective designs.
  110. [110]
    Summary - The Childhood Immunization Schedule and Safety - NCBI
    Recommendation 6-2: The Department of Health and Human Services should refrain from initiating randomized controlled trials of the childhood immunization ...
  111. [111]
    Frequency and impact of confounding by indication and healthy ...
    Oct 17, 2015 · Both confounding by indication and healthy vaccinee bias are likely to operate simultaneously in observational studies on influenza VE.
  112. [112]
    Does the healthy vaccinee bias rule them all? Association of COVID ...
    Healthy vaccinee bias demonstrated on visualizations of the data. •. This bias overestimates COVID-19 vaccine efficiency in observational studies. Abstract ...
  113. [113]
    Frequency and impact of confounding by indication and healthy ...
    Conclusions. Both confounding by indication and healthy vaccinee bias are likely to operate simultaneously in observational studies on influenza VE.
  114. [114]
    T cell immune memory after covid-19 and vaccination - PMC
    Nov 22, 2023 · T cell memory after infection with the SARS-CoV-2 virus or vaccination is broad, and spans multiple viral proteins and epitopes, about 20 in each individual.
  115. [115]
    Role of antiviral CD8+ T cell immunity to SARS-CoV-2 infection and ...
    Mar 3, 2025 · Natural infection induces expansion of multispecific CD8+ T cells in the lung and peripheral blood, whereas (mRNA) vaccination primarily induces ...
  116. [116]
    SARS-CoV-2 T Cell Immunity Responses following Natural Infection ...
    Our findings suggest that natural cellular immunity, either alone or combined with vaccination, confers stronger and more durable protection
  117. [117]
    Coronavirus Disease 2019 (COVID-19) Vaccine Boosting ... - medRxiv
    Feb 13, 2022 · Summary Among 39 766 Cleveland Clinic employees already protected by prior infection or vaccination, vaccine boosting after 6 months was ...
  118. [118]
    Hybrid immunity against COVID-19 in different countries with a ...
    Stamatatos et al. have noted that hybrid immunity provides about 25 to 100 times higher antibody responses than natural and vaccine-produced immunity [26].
  119. [119]
    Women who received varicella vaccine versus natural infection have ...
    Feb 11, 2020 · Conclusion. Natural infection induced higher VZV-specific T cell immune responses than vaccination. Introduction.Missing: studies | Show results with:studies
  120. [120]
    Identifying optimal vaccination scenarios to reduce varicella zoster ...
    Oct 8, 2022 · However, chickenpox vaccine coverage levels above 35% would increase shingles incidence under realistic estimates of shingles coverage with the ...
  121. [121]
    THE AMERICAN ANTI-VACCINATIONISTS AND THEIR ARGUMENTS
    William Tebb, Compulsory Vaccination in England (London, 1884), pp. 50-51, 60-62. 13. Ibid., pp. 47-50. 18. S. R. H. Giles, Compulsory Vaccination (Hyde Park ...
  122. [122]
    THE LEICESTER METHOD
    48 This is not to deny that vaccination did confer some degree of protection against smallpox, but unfortunately the medical benefits had become involved with ...
  123. [123]
    Lora C. Little (1856-1931) – Anti-Vaccinationist
    Oct 30, 2021 · Lora C. Little was a prominent American anti-vaccinationist who, in 1906, stationed herself in central Pennsylvania during the debate over the compulsory ...
  124. [124]
    Lora Cornelia Little - Her Hat Was In The Ring - HistoryIT
    Lora Little ran for Oregon House of Representatives in 1914 on the Progressive ticket and lost. Her primary platform in the campaign involved opposition to ...
  125. [125]
    [PDF] Alfred Russel Wallace and the Antivaccination Movement in ... - CDC
    Alfred Russel Wallace, eminent naturalist and codis- coverer of the principle of natural selection, was a major participant in the antivaccination campaigns ...
  126. [126]
    Alfred Russel Wallace and the Antivaccination Movement in ...
    Wallace concluded from his analysis that smallpox mortality rates increased with vaccination coverage, whereas his opponents concluded the exact opposite.
  127. [127]
    HHS Takes Bold Step to Restore Public Trust in Vaccines by ...
    Jun 9, 2025 · Under the leadership of HHS Secretary Robert F. Kennedy, Jr., the agency removed the 17 sitting members of the ACIP committee and will replace ...Missing: reforms | Show results with:reforms
  128. [128]
    RFK Jr. boots all members of the CDC's vaccine advisory committee
    Jun 9, 2025 · In his role as head of HHS, Kennedy has the legal authority to replace members of the Advisory Committee on Immunization Practices (ACIP) ...Missing: reforms | Show results with:reforms
  129. [129]
    The Most Influential Spreader of Coronavirus Misinformation Online
    Nov 25, 2022 · Researchers and regulators say Joseph Mercola, an osteopathic physician, creates and profits from misleading claims about Covid-19 vaccines.
  130. [130]
    Just 12 People Are Behind Most Vaccine Hoaxes On Social Media ...
    May 13, 2021 · The majority of false claims about COVID-19 vaccines on social media trace back to just a handful of influential figures.Missing: Mercola | Show results with:Mercola
  131. [131]
    Tech millionaire Steve Kirsch went from covid trial funder to ...
    Oct 5, 2021 · After boosting unproven covid drugs like fluvoxamine and ivermectin and campaigning against vaccines, Steve Kirsch was abandoned by his team ...
  132. [132]
    Home | National Vaccine Information Center (NVIC)
    Protecting Health and Informed Consent Rights Since 1982. NVIC is dedicated to preventing vaccine injuries and deaths through public education and securing ...Know the Risks and Failures · About NVIC · State · Vaccines & Diseases
  133. [133]
    NVIC's Vaccination & Health Research Program History and Principles
    The National Vaccine Information Center (NVIC) is a charitable non-profit 501c3 educational organization funded by donations from individuals and family ...
  134. [134]
    Robert F. Kennedy, Jr. Announces The Launch of Children's Health ...
    Sep 12, 2018 · Robert F. Kennedy, Jr. (RFK, Jr.) announced today the creation of Children's Health Defense (CHD), a new organization expanding the mission of the World ...Missing: activities | Show results with:activities
  135. [135]
    History of CHD - Children's Health Defense
    CHD Founder, Robert F. Kennedy Jr., learned well over a decade ago that the movement behind CHD's mission to end childhood health epidemics is primarily fueled ...
  136. [136]
    Children's Health Defense
    View information about our current litigation to protect children's health, support health freedom for all, and to hold governments and corporations accountable ...Leadership Team · Too Many Sick Children · Children's Health Defense Team
  137. [137]
    Litigation Actions - Children's Health Defense
    A series of strategic cases funded by Children's Health Defense that leverages federal disability laws, specifically the ADA, to petition the courts for ...
  138. [138]
    Informed Consent Action Network: Home - ICAN
    Investigating the safety of medical procedures, pharmaceutical drugs, and vaccines while educating the public of their right to “informed consent.”About Us · Get Informed · Vaccine Safety Debate · Report a Vaccine Injury
  139. [139]
    WCH – People-Powered Health Freedom & Integrity
    WCH is a non-profit, people-powered coalition uniting initiatives worldwide to share knowledge defend freedom and promote informed choice.
  140. [140]
    Vaccine Safety Debate - ICAN - Informed Consent Action Network
    In October 2017, ICAN sent HHS a letter demanding that it explain serious and dangerous shortcomings in vaccine safety.
  141. [141]
    Kindergarten Routine Vaccination Rates Continue to Decline - KFF
    Aug 5, 2025 · Seventeen states in the 2024-2025 school year had vaccine exemption rates over 5% compared with nine states during the pre-pandemic school year ...
  142. [142]
    Coverage with Selected Vaccines and Exemption Rates Among ...
    Oct 17, 2024 · Coverage dropped below 93% for the 2023–24 school year, ranging from 92.3% for DTaP to 92.7% for MMR. Exemptions increased to 3.3%, compared with those during ...
  143. [143]
    The pandemic's role in shaping parents' attitudes toward vaccines
    Jan 8, 2024 · In summer 2022, we surveyed parents with children ages 0-17 and found: 11% believed that childhood vaccines are less safe compared to before ...
  144. [144]
    Decline in Vaccination Coverage by Age 24 Months and ... - CDC
    Sep 26, 2024 · This report describes estimated childhood vaccination coverage among children born during 2020–2021.Missing: trials | Show results with:trials
  145. [145]
    Immunization coverage - World Health Organization (WHO)
    Jul 15, 2025 · Globally in 2024, there were 14.3 million children missing out on any vaccination – so-called zero-dose children. Coverage of a third dose ...
  146. [146]
    Global childhood vaccination coverage holds steady, yet over 14 ...
    Jul 15, 2025 · In 2024, 89% of infants globally – about 115 million – received at least one dose of the diphtheria, tetanus and pertussis (DTP)-containing vaccine.
  147. [147]
    Why millions of children still miss life-saving vaccines
    Aug 22, 2025 · Yet, in 2024, there were still 14.3 million zero-dose children – still above the 2019 baseline of 12.8 million – mainly due to slow recovery ...
  148. [148]
    National Update on Measles Cases and Outbreaks — United States, ...
    Oct 11, 2019 · During January 1–October 1, 2019, a total of 1,249 measles cases and 22 measles outbreaks were reported in the United States. This represents ...
  149. [149]
    Measles Cases and Outbreaks - CDC
    A total of 23 measles cases were reported among international visitors to the U.S.. There have been 43 outbreaks** reported in 2025, and 87% of confirmed cases ...National Update on Measles... · Be Ready for Measles Toolkit · History of Measles
  150. [150]
    Tdap Vaccine Effectiveness in Adolescents During the 2012 ...
    May 4, 2015 · Tdap protection wanes within 2 to 4 years. Lack of long-term protection after vaccination is likely contributing to increases in pertussis ...
  151. [151]
    [PDF] Pertussis Epidemic — Washington, 2012 - CDC
    Jul 20, 2012 · Acellular and whole-cell vaccines both have high efficacy during the first 2 years after vaccination, but recent changes in the epidemiology of ...
  152. [152]
    Significant Increase in Excess Deaths after Repeated COVID-19 ...
    Mar 7, 2025 · Another hypothesized cause of the excess deaths is various adverse reactions to COVID-19 vaccinations.
  153. [153]
    COVID-19 mRNA-vaccination and all-cause mortality in the adult ...
    Dec 16, 2024 · We estimate the risk of all-cause mortality by vaccination status in the total adult population in Norway during 2021-2023 and demonstrate a lower rate of all- ...
  154. [154]
    Moderna cuts 2025 sales forecast by $1 bln on weak vaccine ...
    Jan 13, 2025 · Moderna (MRNA.O) cut its 2025 sales forecast by $1 billion on Monday, hurt by a slow adoption of its respiratory syncytial virus (RSV) shot and weak demand for ...Missing: Pfizer booster 2023 actual underperformance
  155. [155]
    Tanking Covid-19 Vaccine Sales Are Crushing Biotech Billionaire ...
    Sep 29, 2025 · In August, Moderna revised its 2025 sales guidance to a range between $1.5 billion to $2.2 billion, which would mark a 32% decline from last ...Missing: projections actual underperformance
  156. [156]
    Moderna lowers top end of revenue guidance as vaccine group ...
    Aug 1, 2025 · The vaccine maker said it now anticipates that annual revenue will come in at $1.5 billion to $2.2 billion, compared to a prior estimate of $1.5 ...Missing: Pfizer booster 2023 2024 actual underperformance
  157. [157]
    Pfizer Provides Full-Year 2025 Guidance and Reaffirms Full-Year ...
    Dec 17, 2024 · Pfizer anticipates full-year 2025 revenues to be in the range of $61.0 to $64.0 billion, which includes the expectation of revenues from our COVID-19 products ...Missing: Moderna underperformance
  158. [158]
    WashU Expert: Vaccine approval changes create economic ...
    Aug 28, 2025 · With the new FDA regulations, it is reasonable to expect that fewer people will be vaccinated, further negatively impacting earnings. While ...
  159. [159]
    HHS Reinforces Religious and Conscience Exemptions from ...
    Sep 4, 2025 · “Today's letter makes clear that providers must respect state laws protecting religious and conscience-based exemptions to vaccine mandates,” ...Missing: expansions | Show results with:expansions
  160. [160]
    Parents seeking religious exemptions to school vaccines win ...
    Jul 24, 2025 · The ruling involves children whose parents sued and are claiming religious exemptions to a long-standing school vaccine mandate. Morrisey issued ...
  161. [161]
    Some 300 W. Virginia School Vaccine Exemptions Granted Under ...
    and approved — ...Missing: wins | Show results with:wins
  162. [162]
    US childhood vaccination rates fall again as exemptions set another ...
    Aug 1, 2025 · The fraction of kids exempted from vaccine requirements rose to 4.1%, up from 3.7% the year before. It's the third record-breaking year in a row ...
  163. [163]
    A Look at Recent Changes to State Vaccine Requirements for ... - KFF
    Sep 12, 2025 · Increases in non-medical exemptions accounted for the recent increases, with non-medical exemptions increasing from 2.2% to 3.4% over the period ...
  164. [164]
    Autism and Vaccines - CDC
    Dec 30, 2024 · No links have been found between any vaccine ingredients and ASD. Vaccines do not cause autism. Autism spectrum disorder (ASD) is a ...
  165. [165]
    Vaccines are not associated with autism: an evidence-based meta ...
    Jun 17, 2014 · There has been enormous debate regarding the possibility of a link between childhood vaccinations and the subsequent development of autism.
  166. [166]
    Research note: Examining how various social media platforms have ...
    Dec 15, 2021 · Facebook, Instagram, YouTube, and Twitter all prohibited misinformation ... Vaccine misinformation in Facebook comment sections: A case study.
  167. [167]
    The efficacy of Facebook's vaccine misinformation policies ... - Science
    Sep 15, 2023 · We found that Facebook removed some antivaccine content, but we did not observe decreases in overall engagement with antivaccine content.
  168. [168]
    Scrutinizing the COVID-19 vaccine safety debate - PMC - NIH
    The controversy surrounding COVID-19 vaccine safety is part of a historical trend of doubts around vaccine safety. A 2024 study suggests a potential link ...
  169. [169]
    Exclusive: US CDC plans study into vaccines and autism, sources say
    Mar 10, 2025 · It is unclear whether Health Secretary Robert F. Kennedy Jr, who has long promoted anti-vaccine views, is involved in the planned study or ...
  170. [170]
    Meta gets rid of fact checkers and says it will reduce 'censorship'
    Jan 7, 2025 · In a number of sweeping changes that will significantly alter the way that posts, videos and other content are moderated online, Meta will ...
  171. [171]
    [PDF] The Facts Behind the “CDC Whistleblower” Accusations Spotlighted ...
    In August 2014, anti-vaccine activists Brian Hooker and Andrew Wakefield released a video of recorded phone conversations with an individual named as Dr.
  172. [172]
    CDC To Revisit Debunked Theory Of Link Between Vaccines And ...
    Mar 8, 2025 · By revisiting debunked theories that link autism to the MMR vaccine, CDC may undermine the public's confidence and lead to further vaccine ...
  173. [173]
    Jacobson v. Massachusetts | 197 U.S. 11 (1905)
    The court ruled that a state can enact compulsory vaccination laws, as it's within the legislature's discretion to decide on the best method for public health.
  174. [174]
    U.S. Supreme Court Blocks OSHA Vaccine Mandate - NFIB
    In a 6-3 decision, the Court concluded that plaintiffs were likely to succeed on the full merits of the case, and blocked OSHA from enforcing the ETS.Missing: natural immunity 2020-2025<|separator|>
  175. [175]
    A Dizzying Map of Federal Vaccination Mandates, Injunctions and ...
    Dec 23, 2021 · Companies need to keep track of the numerous injunctions and stays by multiple federal district courts and courts of appeal involving three ...<|control11|><|separator|>
  176. [176]
    RFK Jr Axes $500 Million in Funding for mRNA Vaccine Development
    Aug 6, 2025 · Kennedy Jr announced plans to cancel 22 mRNA-based vaccine development projects totaling nearly $500 million, citing scientific review and ...
  177. [177]
    HHS scraps further work on life-saving mRNA vaccine platform
    Aug 6, 2025 · ... (HHS) Secretary Robert F. Kennedy Jr. yesterday announced the dismantling of the country's mRNA vaccine-development programs—the same ...Missing: studies | Show results with:studies
  178. [178]
    Florida plans to end all state vaccine mandates, including for schools
    Sep 4, 2025 · Sept 3 (Reuters) - Florida plans to end all state vaccine mandates, including for students to attend schools, the state's surgeon general, ...Missing: shifts | Show results with:shifts
  179. [179]
    European Court: Doctors' Role in COVID 19 Vaccine Administration
    Feb 3, 2025 · ECJ ruling in case C-586/23 P affirms doctors' autonomy in COVID-19 vaccine prescriptions, clarifying liability and legal standing.<|separator|>
  180. [180]
    Case-law - CURIA - Documents - European Union
    Jan 30, 2025 · 1 By his appeal, Mr Giovanni Frajese asks the Court of Justice to set aside the order of the General Court of the European Union of 27 July 2023 ...Missing: HPV | Show results with:HPV
  181. [181]
  182. [182]
    Full article: Is informed consent correctly obtained for vaccinations?
    Informed consent is an integral tenet of medical ethics. However, the United States lacks a standardized consent process for immunizations, with states and ...
  183. [183]
    Coronavirus disease (COVID-19): Herd immunity, lockdowns and ...
    For example, herd immunity against measles requires about 95% of a population to be vaccinated. The remaining 5% will be protected by the fact that measles ...
  184. [184]
    Ethical Issues in Mandating COVID-19 Vaccination for Health Care ...
    At least one court has upheld a hospital's legal right to impose a COVID-19 vaccine mandate. Here we discuss whether vaccine mandates for HCP should be adopted.
  185. [185]
    KFF Tracking Poll on Health Information and Trust: January 2025
    Jan 28, 2025 · Among parents of children under age 18, the large majority say the benefits of the MMR vaccine outweigh the risks, but one in four now say the ...
  186. [186]
    Vitamin A Supplementation of Vitamin A Deficient Measles Patients ...
    ... supplements showed that measles-specific mortality rate was reduced by 50% (7. 7. Sommer, A. Vitamin A prophylaxis. Arch. Dis. Child. 1997; 77:191-194.<|separator|>